Paul Santerre is a chemical engineer. He co-founded Interface Biologics Inc., a Toronto-based health technologies company. He invented Endexo technology, a unique compound of surface-modifying macro-molecules that are added to plastics during the manufacturing process of medical devices. The special coating helps reduce clotting when the devices are used to treat patients, reducing the risk of adverse reactions and potentially deadly complications. Now being used in commercialized products in Canada, the U.S. and Europe, Endexo is helping to improve treatment outcomes for thousands of patients.
On May 23, 2017, Dr. Santerre was one of six winners of the Governor General’s Innovation Awards.
The Governor General’s Innovation Awards inspire Canadians to embrace innovation and to emulate innovative, entrepreneurial risk-takers who have developed new or better ways of creating value and who are having a meaningful impact on our quality of life. For more information, visit https://innovation.gg.ca/.
